The Embarrassment of Riches: Combining SGLT2 Inhibitors and Nonsteroidal Mineralocorticoid Antagonists for the Treatment of Diabetic Kidney Disease

被引：0
|
作者：
Haller, Hermann [1 ,2 ]
机构：
[1] Mt Desert Biol Lab, Bar Harbor, ME 04609 USA
[2] Hannover Med Sch Hannover, Hannover, Germany
来源：
AMERICAN JOURNAL OF NEPHROLOGY | 2021年 / 52卷 / 08期
关键词：
SGLT2; inhibitors; Kidney; Diabetes; Nephropathy; EMPAGLIFLOZIN;
D O I：
10.1159/000516214
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：605 / 607
页数：3
相关论文
共 50 条
  • [1] Are SGLT2 inhibitors a targeted treatment for diabetic kidney disease?
    Kanda, Eiichiro
    Nangaku, Masaomi
    [J]. KIDNEY INTERNATIONAL, 2019, 96 (01) : 8 - 10
  • [2] Nonsteroidal mineralocorticoid antagonists in diabetic kidney disease
    Dojki, Farheen K.
    Bakris, George
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2017, 26 (05): : 368 - 374
  • [3] SGLT2 Inhibitors in Diabetic Kidney Disease
    Zoungas, Sophia
    de Boer, Ian H.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (04): : 631 - 633
  • [4] Mineralocorticoid Receptor Antagonists in the Treatment of Diabetic Kidney Disease: Their Application in the Era of SGLT2 Inhibitors and GLP-1 Receptor Agonists
    Scott Cohen
    Hillel Sternlicht
    George L. Bakris
    [J]. Current Diabetes Reports, 2022, 22 : 213 - 218
  • [5] Mineralocorticoid Receptor Antagonists in the Treatment of Diabetic Kidney Disease: Their Application in the Era of SGLT2 Inhibitors and GLP-1 Receptor Agonists
    Cohen, Scott
    Sternlicht, Hillel
    Bakris, George L.
    [J]. CURRENT DIABETES REPORTS, 2022, 22 (05) : 213 - 218
  • [6] SGLT2 inhibitors to prevent diabetic kidney disease
    Fioretto, Paola
    Vettor, Roberto
    Pontremoli, Roberto
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (01): : 4 - 5
  • [7] SGLT2 inhibitors: diabetic kidney disease and beyond
    Staruschenko, Alexander
    Bhalla, Vivek
    Rangaswami, Janani
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2020, 319 (05) : F780 - F781
  • [8] SGLT2 Inhibitors and the Diabetic Kidney
    Fioretto, Paola
    Zambon, Alberto
    Rossato, Marco
    Busetto, Luca
    Vettor, Roberto
    [J]. DIABETES CARE, 2016, 39 : S165 - S171
  • [9] Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors
    Ralph A. DeFronzo
    W. Brian Reeves
    Alaa S. Awad
    [J]. Nature Reviews Nephrology, 2021, 17 : 319 - 334
  • [10] SGLT2 inhibitors in non-diabetic kidney disease
    Tesar, Vladimir
    [J]. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 31 (02): : 105 - 107
12345